Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)
Tramadol Hydrochloride
Product Images NDC 45865-969
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)
This is a chart showing the concentration of Tramadol (measured in ng/mL) at different time intervals (measured in hours) for two different medications: Tramadol Hydrochloride Extended-Release Tablets, with a dosage of 200 mg once daily, and Tramadol Hydrochloride Tablets with a dosage of 50 mg every 6 hours.*
Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)
This is a graph depicting the concentration of M1 (in ng/mL) over time (in hours) for two different medications: Tramadol Hydrochloride Extended-Release Tablets (200 mg once daily) and Tramadol Hydrochloride Tablets (50 mg every 6 hours). The chart shows the concentration values of M1 ranging from 0 to 120 ng/mL, and the time values ranging from 0 to slightly above 24 hours.*
Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)
This appears to be a graph displaying the percent of patients who have achieved various levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets in Study 023 WOMAC Pain Responder Analysis. Different doses (100mg, 200mg, 300mg, 400mg) of the medication are included and compared to a placebo. The X-axis measures response threshold in percent improvement from baseline while the Y-axis shows the percent of patients achieving that level of response.*
Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)
This is a table displaying the response levels of patients with arthritis pain who were given Tramadol Hydrochloride Extended-Release Tablets (versus a placebo) in Study 015. The percentage of patients achieving various response thresholds are indicated on the left vertical axis, while the Response Threshold (expressed as a percent improvement from baseline) is indicated on the horizontal axis.*
Pdp (969)
This is a label description for Tramadol HCL ER tablets of 100mg strength with a controlled substance classification of CIV. There is no additional information available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
